Allergy provides the readers with 23 free and open access articles in the September issue! Check out the articles and download freely with one click on the doi link. 1. Torres, M.J., Shamji, M., Arasi, S., et al. Decalogue of the Declaration of Salamanca: Advancing Undergraduate Education in Allergy and Clinical Immunology Across Europe. Allergy, 81: 3035-3038. doi.org/10.1111/all.70445 2. F. Roth-Walter, I. M. Adcock, C. Benito-Villalvilla, et al., “ Update on Non-Biological and RNA-Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper,” Allergy 81, no. 9 (2026): 3039–3070, doi.org/10.1111/all.70235 3. S. Scheire, E. Lourijsen, M. Blauwblomme, et al., “ Meta-Analysis on the Harm of Systemic Glucocorticosteroids in Inflammatory Upper Airway Disease and Asthma: An EAACI Task Force,” Allergy 81, no. 9 (2026): 3071–3106, doi.org/10.1111/all.70332 4. F. E. Gunaydin, G. Marcassa, B. Olivieri, et al., “ Is Asthma Remission a New Achievable Goal? A Review of the Current Drug-Related Evidence and Predictors,” Allergy 81, no. 9 (2026): 3107–3129, doi.org/10.1111/all.70388 5. T. H. Nguyen, C. A. Akdis, A. Baccarelli, et al., “ Leveraging Artificial Intelligence in Allergy, Asthma, and Immunology With Environmental Exposures,” Allergy 81, no. 9 (2026): 3130–3145, doi.org/10.1111/all.70401 6. J. C. Virchow, X. Bertels, V. Backer, et al., “ Remission in Global Airway Diseases: EUFOREA Consensus Paper,” Allergy 81, no. 9 (2026): 3146–3156, doi.org/10.1111/all.70415 7. S. Gangemi, S. Manti, J. C. Virchow, and G. W. Canonica, “ Targeting Airway Remodeling in Severe Asthma: Is There a Window of Opportunity for Biologic Therapy Predicting Effects Using Causal Artificial Intelligence?,” Allergy 81, no. 9 (2026): 3157–3170, doi.org/10.1111/all.70468 8. E. Matsuyama, J. Miyata, T. Mochimaru, et al., “ IL-33 Drives Inflammatory Changes and Extracellular Trap Formation in Eosinophils Involving Oxidised LDL and Complement Pathways,” Allergy 81, no. 9 (2026): 3171–3184, doi.org/10.1111/all.70313 9. A. Kumar, R. Chan, N. Zounemat-Kermani, et al., “ Small Airways Dysfunction and Remission in Adults With Asthma: A Longitudinal Exploratory Analysis of the AssessmenT of smalL Airways involvemeNT In aSthma (ATLANTIS) Study,” Allergy 81, no. 9 (2026): 3185–3196, doi.org/10.1111/all.70264 10. H. Wen, T. Kole, O. A. Carpaij, et al., “ Nasal Airway Transcriptome Reflects Selected Asthma-Associated Gene Signatures in the Lower Airways,” Allergy 81, no. 9 (2026): 3197–3205, doi.org/10.1111/all.70283 11. L. I. Andersson, M. Kupczyk, B. Dahlén, et al., “ Adipokines in Obese Asthma: A Complex Relationship Influenced More by Sex, Weight, and Oral Steroid Treatment Than Disease Severity,” Allergy 81, no. 9 (2026): 3206–3220, doi.org/10.1111/all.70318 12. P. S. Pathinayake, A. C. Brown, N. T. Awatade, et al., “ Resolving Endoplasmic Reticulum-Protein Misfolding Restores Corticosteroid Sensitivity in Experimental Models of Severe Asthma,” Allergy 81, no. 9 (2026): 3221–3235, doi.org/10.1111/all.70353 13. A. M. Cannata, J. W. McAlees, J. M. Hargis, et al., “ MAIT Cells Suppress IgE-Mediated Asthma via IFNγ-Dependent B Cell Regulation,” Allergy 81, no. 9 (2026): 3236–3249, doi.org/10.1111/all.70384 14. M. E. Wechsler, S. E. Wenzel, S. D. Groshong, et al., “ Effect of Dupilumab on Airway Inflammation in Patients With Persistent Asthma,” Allergy 81, no. 9 (2026): 3261–3272, doi.org/10.1111/all.70391 15. W.-J. Song, N. Z. Kermani, A. Versi, et al., “ Clinical Features of Cellular Senescence Pathways in Severe Asthma,” Allergy 81, no. 9 (2026): 3273–3285, doi.org/10.1111/all.70416 16. F. Yang, S. Seo, T. Hasegawa, et al., “ Longer Asthma Duration Is Associated With Elevated Non-T2 Sputum Biomarkers and Reduced T2 Inflammation in Severe Asthma,” Allergy 81, no. 9 (2026): 3286–3299, doi.org/10.1111/all.70436 17. J. Shen, R. Chaudhuri, S. Bicknell, et al., “ The Airway Transcriptome in Type 2 Cytokine Biomarker-High and -Low Severe Asthma,” Allergy 81, no. 9 (2026): 3300–3317, doi.org/10.1111/all.70441 18. J. D. Hamilton, M. A. R. Ferreira, W. K. Lim, et al., “ Type-2-Inflammatory-Diseases Share Comorbidities, Molecular Signatures, IL4/IL13 Genetics, and Response to IL4/IL13 Blockade,” Allergy 81, no. 9 (2026): 3345–3360, doi.org/10.1111/all.70380 19. H.-C. Chang, M.-C. Wu, T. Zuberbier, and S.-Y. Gau, “ Anxiety, Depression, Schizophrenia, and Bipolar Disorder in Eosinophilic Esophagitis Patients: A Global Federated Cohort Analysis of Bidirectional Risks,” Allergy 81, no. 9 (2026): 3361–3364, doi.org/10.1111/all.70288 20. M. C. Melles, J. C. C. M. Veen, D.-J. Slebos, et al., “ Prevalence of Type 2 Inflammation in Chronic Obstructive Pulmonary Disease Patients With Frequent Exacerbations,” Allergy 81, no. 9 (2026): 3365–3367, doi.org/10.1111/all.70300 21. C. Handoko, A. Singh, S. C. Dharmage, et al., “ The Impact of Early Childhood Caries on Asthma Trajectories During the First 15 Years of Life,” Allergy 81, no. 9 (2026): 3368–3371, doi.org/10.1111/all.70307 22. J. Bernaola, J. A. Cañas, Á. Arranz-Fragua, et al., “ Differential Effects of Benralizumab and Mepolizumab on Pro-Resolving Mediators,” Allergy 81, no. 9 (2026): 3377–3383, doi.org/10.1111/all.70356 23. P.-H. Lee, S. Yoon, C. Lee, and A.-S. Jang, “ Moesin, a Cytoskeletal-Associated Protein, Outperforms Candidate Biomarkers in Identifying Asthma Exacerbation,” Allergy 81, no. 9 (2026): 3384–3386, doi.org/10.1111/all.70389 #Allergy_journal Read all recent papers published in #Allergy here: journalallergy.com